DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
AD1190412
Title:
Treatment Options and Survival of Metastatic Prostate Cancer Patients
Descriptive Note:
[Technical Report, Annual Report]
Corporate Author:
WASHINGTON UNIV ST LOUIS MO
Report Date:
2022-06-01
Pagination or Media Count:
11
Abstract:
In this proposal, we will utilize a prostate cancer cohort from the VA hospitals to explorethe survival benefit among men diagnosed with metastatic prostate cancer who receivedefinitive treatment alone or with adjuvant therapies compared to men who receive nondefinitive treatment and we will assess the treatment related side effects that affect quality of life among men diagnosed with metastatic prostate cancer who receive definitivevs. non-definitive treatment. The specific aims areAim 1 To examine the survival benefit among men diagnosed with metastatic prostatecancer that receive definitive treatment compared to men that receive non-definitivetreatment.
Distribution Statement:
[A, Approved For Public Release]